The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Salvatore Geraci
Showing 1-8 of 8 articles
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
Schnorbus B,
Wiebe J,
Capodanno D,
Brugaletta S,
Geraci S,
Mehilli J,
Latib A,
Lesiak M,
Jensen C,
Mattesini A,
Munzel T,
Capranzano P,
Di Mario C,
Naber CK,
Araszkiewicz A,
Colombo A,
Caramanno G,
Sabaté M,
Tamburino C,
Nef H,
Gori T
October 11, 2017 | 10.4244/EIJ-D-16-00568
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)
Testa L,
De Carlo M,
Petrolini A,
Rapetto C,
Varbella F,
Cortese B,
Gabrielli G,
Geraci S,
Loi B,
Boccuzzi G,
Tarantini G,
Fischetti D,
Calabria P,
Tomai F,
Ribichini F,
Tamburino C,
Indolfi C,
Bartorelli AL,
Petronio AS,
Bedogni F
July 20, 2017 | 10.4244/EIJ-D-17-00246
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
Ortega-Paz L,
Capodanno D,
Gori T,
Nef H,
Latib A,
Caramanno G,
Di Mario C,
Naber CK,
Lesiak M,
Capranzano P,
Wiebe J,
Mehilli J,
Araszkiewicz A,
Pyxaras S,
Mattesini A,
Geraci S,
Naganuma T,
Colombo A,
Munzel T,
Sabaté M,
Tamburino C,
Brugaletta S
April 20, 2017 | 10.4244/EIJ-D-16-00974
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
Gori T,
Wiebe J,
Capodanno D,
Latib A,
Lesiak M,
Pyxaras S,
Mehilli J,
Caramanno G,
Di Mario C,
Brugaletta S,
Weber J,
Capranzano P,
Sabaté M,
Mattesini A,
Geraci S,
Naber CK,
Araszkiewicz A,
Colombo A,
Tamburino C,
Nef H,
Munzel T
August 5, 2016 | 10.4244/EIJY15M09_10
Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience
Ielasi A,
Miyazaki T,
Geraci S,
Testa L,
Abdel-Wahab M,
Kawamoto H,
Ruparelia N,
Sato T,
Caramanno G,
Bedogni F,
Tespili M,
Colombo A,
Latib A
April 8, 2016 | 10.4244/EIJV11I14A309
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective
Tamburino C,
Latib A,
van Geuns R,
Sabaté M,
Mehilli J,
Gori T,
Achenbach S,
Alvarez M,
Nef H,
Lesiak M,
Di Mario C,
Colombo A,
Naber CK,
Caramanno G,
Capranzano P,
Brugaletta S,
Geraci S,
Araszkiewicz A,
Mattesini A,
Pyxaras S,
Rzeszutko L,
Depukat R,
Diletti R,
Boone E,
Capodanno D,
Dudek D
May 19, 2015 | 10.4244/EIJY15M01_05
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
Capodanno D,
Gori T,
Nef H,
Latib A,
Mehilli J,
Lesiak M,
Caramanno G,
Naber CK,
Di Mario C,
Colombo A,
Capranzano P,
Wiebe J,
Araszkiewicz A,
Geraci S,
Pyxaras S,
Mattesini A,
Naganuma T,
Munzel T,
Tamburino C
February 20, 2015 | 10.4244/EIJY14M07_11
How should I treat a massive thrombus embolisation in the left coronary artery during chronic total occlusion revascularisation?
Geraci S,
La Manna A,
Tamburino C
November 20, 2012 | 10.4244/EIJV8I7A130
1
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023